Loading...
Outcomes with durvalumab by tumour PD-L1 expression in unresectable, Stage III non-small-cell lung cancer in the PACIFIC trial
Paz-Ares, L Spira, A Raben, D Planchard, D Cho, BC Ozguroglu, M Daniel, D Villegas, A Vicente, D Hui, R
Paz-Ares, L
Spira, A
Raben, D
Planchard, D
Cho, BC
Ozguroglu, M
Daniel, D
Villegas, A
Vicente, D
Hui, R
Citations
Altmetric:
Abstract
Description
Date
2020
Publisher
Collections
Keywords
Type
Article
Citation
Paz-Ares L, Dziadziuszko R, Drilon A, John T, Krebs M, Demetri G, et al. Entrectinib in Patients with NTRK Fusion-Positive Solid Tumors or ROS1-Positive NSCLC with CNS Metastases. Oncology Research and Treatment. 2020;43:235-